Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.142
-0.008 (-0.70%)
Apr 30, 2026, 12:59 PM CET
Intervacc AB Employees
Intervacc AB had 16 employees as of December 31, 2025. The number of employees increased by 1 or 6.67% compared to the previous year.
Employees
16
Change
1
Growth
6.67%
Revenue / Employee
1.26M SEK
Profits / Employee
-5.05M SEK
Market Cap
391.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16 | 1 | 6.67% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 2 | 15.38% |
| Dec 31, 2021 | 13 | 1 | 8.33% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 75 |
| Sprint Bioscience AB | 30 |
| Bio-Works Technologies AB | 26 |
| Mendus AB | 20 |
| Xintela AB | 13 |
| Corline Biomedical AB | 12 |
| Ascelia Pharma AB | 10 |
| FluoGuide | 7 |
Intervacc AB News
- 2 months ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Reports Q4 2025 Result - GuruFocus
- 5 months ago - What To Expect From Intervacc AB (OSTO:IVACC) Q3 2025 Earnings - GuruFocus